WO2025217612 - SUBSTITUTED BENZYLPYRROLIDINES AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2025/217612
Publication Date
16.10.2025
International Application No.
PCT/US2025/024418
International Filing Date
11.04.2025
Title **
[English]
SUBSTITUTED BENZYLPYRROLIDINES AND USES THEREOF
[French]
BENZYLPYRROLIDINES SUBSTITUÉES ET LEURS UTILISATIONS
Applicants **
DWULET, Gregory
Inventors
DWULET, Gregory
Priority Data
63/632,552
11.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4837 | |
| EPO | Filing, Examination, Granting | 69841 | |
| Japan | Filing, Examination, Granting | 4859 | |
| South Korea | Filing, Examination, Granting | 7857 | |
| USA | Filing, Examination, Granting | 25910 |
Total:
113,304
Contact Us
Abstract[English]
This disclosure relates in some aspects to novel compounds comprising a substituted benzylpyrrolidine pharmacophore, and analogs thereof. In some aspects, the disclosure further relates to compositions containing the compounds, methods of synthesizing the compounds, and methods of using the compounds. In some aspects, the compounds are useful as therapeutic agents for treating medical conditions, for example by modulating neurotransmission.[French]
La présente divulgation concerne, selon certains aspects, de nouveaux composés comprenant un pharmacophore de benzylpyrrolidine substituée, et des analogues de ceux-ci. Selon certains aspects, la divulgation concerne en outre des compositions contenant les composés, des procédés de synthèse des composés, et des procédés d'utilisation des composés. Dans certains aspects, les composés sont utiles en tant qu'agents thérapeutiques pour traiter des états médicaux, par exemple par modulation de la neurotransmission.